Logo image of ALVAP.PA

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

EPA:ALVAP - Euronext Paris - Matif - FR0013419876 - Common Stock - Currency: EUR

4.75  +0.09 (+1.93%)

Fundamental Rating

6

Taking everything into account, ALVAP scores 6 out of 10 in our fundamental rating. ALVAP was compared to 53 industry peers in the Specialty Retail industry. ALVAP has only an average score on both its financial health and profitability. ALVAP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALVAP had positive earnings in the past year.
ALVAP had positive earnings in each of the past 5 years.
ALVAP had negative operating cash flow in 4 of the past 5 years.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

ALVAP has a Return On Assets of 11.93%. This is amongst the best in the industry. ALVAP outperforms 90.57% of its industry peers.
The Return On Equity of ALVAP (19.68%) is better than 86.79% of its industry peers.
ALVAP has a better Return On Invested Capital (17.26%) than 90.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALVAP is significantly above the industry average of 9.07%.
The 3 year average ROIC (14.54%) for ALVAP is below the current ROIC(17.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.93%
ROE 19.68%
ROIC 17.26%
ROA(3y)10.22%
ROA(5y)8.85%
ROE(3y)15.46%
ROE(5y)14.08%
ROIC(3y)14.54%
ROIC(5y)14.31%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

ALVAP has a better Profit Margin (3.16%) than 75.47% of its industry peers.
ALVAP's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 4.84%, ALVAP is doing good in the industry, outperforming 71.70% of the companies in the same industry.
In the last couple of years the Operating Margin of ALVAP has declined.
ALVAP's Gross Margin of 22.53% is on the low side compared to the rest of the industry. ALVAP is outperformed by 69.81% of its industry peers.
In the last couple of years the Gross Margin of ALVAP has grown nicely.
Industry RankSector Rank
OM 4.84%
PM (TTM) 3.16%
GM 22.53%
OM growth 3Y-6.99%
OM growth 5YN/A
PM growth 3Y-6.57%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALVAP is creating value.
ALVAP has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ALVAP has a worse debt to assets ratio.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 6.38 indicates that ALVAP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.38, ALVAP belongs to the best of the industry, outperforming 98.11% of the companies in the same industry.
A Debt/Equity ratio of 0.26 indicates that ALVAP is not too dependend on debt financing.
ALVAP has a better Debt to Equity ratio (0.26) than 79.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 6.38
ROIC/WACC2.38
WACC7.26%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

ALVAP has a Current Ratio of 3.49. This indicates that ALVAP is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALVAP (3.49) is better than 94.34% of its industry peers.
ALVAP has a Quick Ratio of 1.89. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
ALVAP's Quick ratio of 1.89 is amongst the best of the industry. ALVAP outperforms 86.79% of its industry peers.
Industry RankSector Rank
Current Ratio 3.49
Quick Ratio 1.89
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

ALVAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.14%, which is quite good.
The Earnings Per Share has been growing by 28.22% on average over the past years. This is a very strong growth
ALVAP shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.66%.
The Revenue has been growing by 40.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)11.14%
EPS 3Y28.22%
EPS 5YN/A
EPS Q2Q%-18.21%
Revenue 1Y (TTM)53.66%
Revenue growth 3Y40.66%
Revenue growth 5YN/A
Sales Q2Q%2.01%

3.2 Future

The Earnings Per Share is expected to grow by 4.97% on average over the next years.
Based on estimates for the next years, ALVAP will show a small growth in Revenue. The Revenue will grow by 2.38% on average per year.
EPS Next Y-2.41%
EPS Next 2Y1.2%
EPS Next 3Y4.97%
EPS Next 5YN/A
Revenue Next Year1.16%
Revenue Next 2Y1.36%
Revenue Next 3Y2.38%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.95, which indicates a rather cheap valuation of ALVAP.
ALVAP's Price/Earnings ratio is rather cheap when compared to the industry. ALVAP is cheaper than 94.34% of the companies in the same industry.
ALVAP is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 5.43, the valuation of ALVAP can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALVAP is valued cheaper than 94.34% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ALVAP is valued rather cheaply.
Industry RankSector Rank
PE 4.95
Fwd PE 5.43
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALVAP is valued cheaply inside the industry as 90.57% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.68
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ALVAP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.2%
EPS Next 3Y4.97%

More info and screens

4

5. Dividend

5.1 Amount

ALVAP has a Yearly Dividend Yield of 3.22%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.87, ALVAP pays a better dividend. On top of this ALVAP pays more dividend than 84.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, ALVAP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.22%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.05 0.1

5.3 Sustainability

DPN/A
EPS Next 2Y1.2%
EPS Next 3Y4.97%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 2M -2M 4M

More info and screens

KUMULUS VAPE

EPA:ALVAP (3/7/2025, 7:00:00 PM)

4.75

+0.09 (+1.93%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap14.58M
Analysts86
Price Target8.82 (85.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.22%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.81%
PT rev (3m)-2.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-8.47%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.1%
Revenue NY rev (3m)-4.1%
Valuation
Industry RankSector Rank
PE 4.95
Fwd PE 5.43
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 1.31
EV/EBITDA 2.68
EPS(TTM)0.96
EY20.21%
EPS(NY)0.88
Fwd EY18.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS30.2
BVpS4.84
TBVpS3.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.93%
ROE 19.68%
ROCE 23.81%
ROIC 17.26%
ROICexc 24.45%
ROICexgc 33.91%
OM 4.84%
PM (TTM) 3.16%
GM 22.53%
FCFM N/A
ROA(3y)10.22%
ROA(5y)8.85%
ROE(3y)15.46%
ROE(5y)14.08%
ROIC(3y)14.54%
ROIC(5y)14.31%
ROICexc(3y)19.15%
ROICexc(5y)21.12%
ROICexgc(3y)22.01%
ROICexgc(5y)23.52%
ROCE(3y)20.08%
ROCE(5y)19.87%
ROICexcg growth 3Y-11.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-20.68%
ROICexc growth 5YN/A
OM growth 3Y-6.99%
OM growth 5YN/A
PM growth 3Y-6.57%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover3.78
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 0.76
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.49
Quick Ratio 1.89
Altman-Z 6.38
F-ScoreN/A
WACC7.26%
ROIC/WACC2.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3Y28.22%
EPS 5YN/A
EPS Q2Q%-18.21%
EPS Next Y-2.41%
EPS Next 2Y1.2%
EPS Next 3Y4.97%
EPS Next 5YN/A
Revenue 1Y (TTM)53.66%
Revenue growth 3Y40.66%
Revenue growth 5YN/A
Sales Q2Q%2.01%
Revenue Next Year1.16%
Revenue Next 2Y1.36%
Revenue Next 3Y2.38%
Revenue Next 5YN/A
EBIT growth 1Y22.47%
EBIT growth 3Y30.83%
EBIT growth 5YN/A
EBIT Next Year14.88%
EBIT Next 3Y12.01%
EBIT Next 5YN/A
FCF growth 1Y299.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y413.64%
OCF growth 3YN/A
OCF growth 5YN/A